A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D.
Hawthorne T, Giot L, Blake L, Kuang B, Gerwien R, Smithson G, Hahne W, Mansfield T, Starling GC, Pochart P, Hoelscher D, Halvorsen YD.
Hawthorne T, et al. Among authors: starling gc.
Int J Clin Pharmacol Ther. 2008 May;46(5):236-44. doi: 10.5414/cpp46236.
Int J Clin Pharmacol Ther. 2008.
PMID: 18538109
Clinical Trial.